K substitute) outflow from prelabelled and perifused rat pancreatic islets. This property appears to be inherent to the phenylalkylamine Ca 2 + channel blockers since gallopamil, a methoxyderivative of verapamil, but not nifedipine, a 1,4-dihydropyridine Ca 2 + channel blocker, inhibited 86 Rb outflow. The experimental data further revealed that verapamil interacted with a Ca 2 + -independent, glucose-and glibenclamide-sensitive modality of 86 Rb extrusion. Moreover, verapamil prevented the increase in 86 Rb outflow brought about by BPDZ 44; a potent activator of the ATP-sensitive K + channel. Singlechannel current recordings by the patch clamp technique confirmed that verapamil elicited a dose-dependent inhibition of the ATP-dependent K + channel. Lastly, under experimental conditions in which verapamil clearly inhibited the ATP-sensitive K + channels, the drug did not affect 45 Ca outflow, the cytosolic free Ca 2 + concentration or insulin release. It is concluded that the Ca 2 + entry blocker verapamil inhibits ATP-sensitive K + channels in pancreatic beta cells. This effect was not associated with stimulation of insulin release [Diabetologia (1997) Keywords Verapamil, ATP-sensitive K + channel, rat pancreatic beta cells, insulin release.
the K + permeability of pancreatic beta cells. The identity of K + channels affected by the phenylalkylamine was, however, not determined.
Because K + channels play a crucial role in the control of the insulin releasing process, we have reassessed in the present study the effect of verapamil on beta-cell K + permeability.
Materials and methods
Animals. All experiments were performed with pancreatic islets isolated by the collagenase method from fed female albino rats ( ± 200 g) (Proefdierencentrum, Heverlee, Belgium). Principles of laboratory animal care as well as Belgian regulations were strictly followed.
Measurements of insulin release from incubated pancreatic islets.
Groups of 10 islets, each derived from the same batch of islets, were preincubated for 30 min at 37°C in 1 ml of a bicarbonatebuffered solution (in mmol/l: 115 NaCl, 5 KCl, 2.56 CaCl 2 , 1 MgCl 2 , 24 NaHCO 3 ) supplemented with 2.8 mmol/l glucose, 0.5 % (w/v) dialysed albumin (fraction V) and equilibrated with a mixture of O 2 (95 %) and CO 2 (5 %). The islets were then incubated at 37°C for a further 90 min in 1 ml of the same bicarbonate buffered medium containing 0, 5.6 or 11.1 mmol/l glucose and, in addition, increasing concentrations of verapamil. Individual experiments were carried out as triplicate measurements with the values corresponding to the number of samples pooled. Due to the islet-related variations, insulin release was expressed as percentage of the value recorded in control experiments (100 %), i. e. in the absence of drug and presence of 0, 5.6 or 11.1 mmol/l glucose. The release of insulin was measured radioimmunologically using rat insulin as a standard [7] .
Measurements of 86
Rb, 45 Ca outflow and insulin release from perifused pancreatic islets. Ca outflow and insulin release from perifused islets have been described previously [8, 9] . The outflow of 86 Rb or 45 Ca (cpm/min) was expressed as a fractional outflow rate (% of instantaneous islet content/min; FOR). The validity of 86 Rb as a tracer for the study of K + handling in the islets has been previously assessed [10] .
Patch clamp measurements. Electrophysiological studies were carried out with the patch clamp technique [11] on primary cultured rat islet cells, as previously described [12] . Insulin secreting cells were selected on the basis of their larger size [13] . Single-channel currents were recorded using the cell-free, insideout patch-clamp configuration. Unitary current events from K + ATP channels were recorded at a membrane potential of 0 mV. Under these experimental conditions, with the intracellular Ca 2 + buffered to below 10 nmol/l, openings of Ca 2 + -and voltage-gated K + channels were not observed [14, 15] . Modulation of K + ATP channels was described in terms of a change in the channel open-state probability [15] . In the record illustrated, upward deflections from the baseline represent outward single-channel events.
Measurements of fura 2 fluorescence from single islet cells. Pancreatic islets were disrupted in a Ca 2 + -deprived medium and then centrifuged through an albumin solution to remove debris and dead cells. Cells were seeded onto glass coverslips and maintained in tissue culture for 72 h. Fura-2 fluorescence of single loaded cells (selected on the basis of their larger size) was measured by use of dual-excitation microfluorimetry with a Spex photometric system (Optilas, Alphen aan den Rijn, Holland [15] ). The excitation and emission wavelengths were set at 340/380 and 510 nm, respectively. [Ca 2 + ] i was calculated as previously described [16] . All experiments were repeated at least 3 times, on different days. [15, 17] . Experiments were conducted with minimal light to prevent photodegradation of the dihydropyridines. When high concentrations of extracellular K + were used, the concentration of extracellular NaCl was lowered to keep the osmolarity constant. Statistical analysis. Results are expressed as mean ± SEM. The statistical significance of differences between mean data was assessed by using Student's t-test or by analysis of variance for multiple comparisons followed by a Scheffe test procedure.
Drugs

Results
Effects of verapamil on insulin release from incubated rat pancreatic islets. The addition of verapamil (10 and 100 mmol/l) to islets incubated in a glucose-free medium did not modify the insulin output (p > 0.05) ( Table 1 ). In islets exposed to 5.6 mmol/l glucose, 10 mmol/l verapamil failed to affect (p > 0.05) while 100 mmol/l verapamil tended to slightly, although not significantly, increase insulin release (p > 0.05) (Table 1). When the incubation medium was enriched with an insulinotropic glucose concentration (11.1 mmol/l), verapamil provoked a marked decrease in insulin output (p < 0.05) ( Table 1 ). This inhibitory effect of verapamil was concentration-dependent.
Effects of verapamil on
86 Rb, 45 Ca outflow and insulin release from pancreatic islets perifused in the absence of extracellular glucose. In the absence of glucose in the extracellular medium, verapamil (10 mmol/l) provoked a rapid and sustained inhibition of Rb outflow rate was consistently noticed. The capacity of verapamil (10 mmol/l) to inhibit 86 Rb FOR was identical whether the perifusing medium contained or was deprived of extracellular Ca 2 + (Fig. 2, upper panel) . Thus, the paired difference in 86 Rb FOR before (min 40±44) and during (min 60±68) exposure to verapamil averaged 2.43 ± 0.12 %/min in the presence and 2.57 ± 0.08 %/min in the absence of extracellular Ca 2 + , respectively (p > 0.05). Rat pancreatic islets incubated for 90 min in the absence or presence of extracellular glucose. Insulin release (mean values ± SEM) expressed as a percentage of the value recorded in control experiments (100 %; no verapamil and presence of either 0, 5.6 or 11.1 mmol/l glucose). Figures in parentheses refer to number of samples In the absence or presence of extracellular Ca 2 + , verapamil (10 mmol/l) did not affect 45 Ca outflow from perifused pancreatic islets (Fig. 2, middle panel) .
Verapamil (10 mmol/l) also failed to modify the insulin output from islets exposed to a glucose-deprived and Ca 2 + -containing medium (Fig. 2, lower panel) . At a higher concentration (100 mmol/l), verapamil again provoked a rapid, sustained and reversible decrease in 86 Rb outflow. The magnitude of the inhibitory effect of 100 mmol/l verapamil (3.67 ± 0.12 %/ min) was unaffected by the removal of extracellular Ca 2 + (4.10 ± 0.33 %/min; p > 0.05) but was more pronounced than that recorded at a lower concentration (10 mmol/l; p < 0.05) (data not shown). Moreover, exposure to verapamil (100 mmol/l) did not increase 45 Ca outflow or the insulin secretory rate (data not shown).
Incidentally, verapamil (10 mmol/l) inhibited the increase in Effects of gallopamil and nifedipine on 86 Rb outflow from pancreatic islets perifused in the absence of extracellular glucose. Gallopamil (10 mmol/l), a methoxy derivative of verapamil, induced a marked reduction in 86 Rb outflow from islets perifused in the absence of extracellular glucose (Fig. 3) . The pattern of such an inhibitory effect was not altered in the absence of extracellular Ca 2 + (data not shown, p > 0.05). The slow increase in 86 Rb outflow recorded on removal of the drug reflects relief from inhibitory effect of gallopamil.
By contrast, the 1,4-dihydropyridine nifedipine did not affect the 86 Rb FOR which slowly decreased throughout the perifusion period (Fig. 3) . Whether the physiological medium contained or was deprived of extracellular Ca 2 + (data not shown), nifedipine (10 mmol/l) failed to modify the rate of 86 Rb outflow. The addition of nifedipine (10 mmol/l) also failed to affect the 45 Ca FOR from islets exposed throughout to a glucose-free medium and perifused in the presence or absence of extracellular Ca 2 + (data not shown).
86 Rb, 45 Ca outflow and insulin release from islets perifused in the absence and presence of glucose or glibenclamide. As mentioned above, addition of verapamil (10 mmol/l) to a glucose-free medium elicited a rapid, marked and slowly reversible decrease in 86 Rb outflow (Fig. 4, left panel) . The presence of increasing concentrations of glucose in the physiological medium reduced in a dose-dependent manner the basal 86 Rb outflow (p < 0.05, in each case) and attenuated the effect of verapamil (Fig. 4, left   panel) . Indeed, in the presence of 5.6 and 11.1 mmol/l glucose throughout, the magnitude of the inhibitory effect of verapamil (10 mmol/l) was reduced by 65 % (p < 0.05) and 86 % (p < 0.05), respectively.
Verapamil (10 mmol/l) did not affect 45 Ca outflow or insulin output from islets perifused throughout in the presence of 5.6 mmol/l glucose and extracellular Ca 2 + (data not shown). However, the addition of verapamil (10 and 100 mmol/l) induced a concentrationdependent decrease in both the 45 Ca outflow and the insulin secretory rate from islets perifused throughout in the presence of 11.1 mmol/l glucose and extracellular Ca 2 + (data not shown). In islets exposed to a Ca 2 + -free medium containing either 5.6 or 11.1 mmol/l glucose, the addition of verapamil (10 mmol/l) failed to cause any modification in 45 Ca outflow rate (data not shown).
The continuous presence of the hypoglycaemic sulfonylurea glibenclamide in the perifusing medium modified the cationic response to verapamil in a manner similar to extracellular glucose (Fig. 4, right panel) . Firstly, the basal rate of 86 Rb outflow was lower in the presence than in the absence of glibenclamide (10 mmol/l) throughout (p < 0.05). Secondly, with glibenclamide (10 mmol/l) in the basal medium, the capacity of verapamil (10 mmol/l) to inhibit 86 Rb FOR averaged only 41.6 ± 3.2 % of that recorded in the absence of the hypoglycaemic sulfonylurea (p < 0.05). Effects of verapamil on BPDZ 44-induced changes in 86 Rb outflow. As previously described [18] , the K + ATP channel opener BPDZ 44 (50 mmol/l) increased 86 Rb FOR from islets perifused in the presence of 5.6 mmol/l glucose and extracellular Ca 2 + (Fig. 5) . When the same experiment was repeated with verapamil (10 mmol/l) present throughout, the basal rate of Effects of verapamil on K + ATP channel activity. The effects of verapamil on K + ATP channel activity were further studied using the inside-out configuration of the patch-clamp technique. Under these experimental conditions, verapamil consistently inhibited K + ATP channels at 10 (n = 13/14 occasions in 14 patches) and 100 mmol/l (n = 17/17 in 17 patches) concentrations (Fig. 6, upper panel) . In 6 patches which were suitable for a detailed quantification of channel activity, 10 mmol/l verapamil decreased the K + ATP channels' open state probability to 26.2 ± 15.4 % and 100 mmol/l verapamil to 9.5 ± 1.5 % of the control value recorded immediately prior to the addition of the drug (Fig. 6, lower panel) . The effects of verapamil were sustained but not readily reversible at either concentration (Fig. 6, lower panel) . Open state probability averaged 57.5 ± 16.0 % and 34.6 ± 16.5 % of the control value 2−3 min after the withdrawal of 10 and 100 mmol/l verapamil, respectively. Following removal of verapamil, the addition of ATP (500 mmol/l) on the inside face of the beta-cell membrane was Rb outflow from islets perifused in the absence (k) or presence of verapamil (U; 10 mmol/l) throughout. Basal media contained 5.6 mmol/l glucose and extracellular Ca 2 + . Mean values ± SEM refer to 4±8 individual experiments associated with a reduction in K channel openings (Fig. 6, upper panel) .
Effect of verapamil on the cytosolic free Ca 2 + concentration. The addition of 10 or 100 mmol/l verapamil did not affect the fluorescence intensity of fura 2-loaded islet cells perifused in the absence (data not shown) or presence of 2.8 mmol/l extracellular glucose (Fig. 7 a, b) . By contrast, in single cells exposed to an insulinotropic glucose concentration (11.1 mmol/l), verapamil (10 and 100 mmol/l) provoked a marked and sustained reduction in the cytosolic Ca 2 + concentration (Fig. 7 c, d ).
Discussion
The results clearly show that verapamil provokes a concentration-related inhibition of 86 Rb outflow from perifused rat pancreatic islets. This response was not due to any direct toxicity of the drug since the inhibitory effect on 86 Rb outflow was reversible. Thus, the present findings suggest that the phenylalkylamine reduces the K + permeability of the pancreatic beta cell. This property appears to be inherent to the phenylalkylamine Ca 2 + channel blockers since gallopamil, another phenylalkylamine derivative, but not nifedipine, a 1,4-dihydropyridine Ca 2 + channel blocker, reproduced the inhibitory effects of verapamil.
Our data also provide information about the type of K + channel affected by verapamil. Firstly, the inhibitory effect of verapamil on 86 Rb FOR was shown to be identical whether the medium contained or was deprived of extracellular Ca 2 + . Secondly, the hypoglycaemic sulfonylurea glibenclamide reduced the capacity of verapamil to inhibit 86 Rb outflow, indicating that the effects of verapamil and the hypoglycaemic sulfonylurea were not additive. Thirdly, the magnitude of the inhibitory effect of verapamil was reduced in a concentration-dependent manner by glucose. These findings reveal that verapamil interacts with a Ca 2 + -independent, glucose-and hypoglycaemic sulfonylurea-sensitive 86 Rb efflux pathway. Such features suggest indirectly that the phenylalkylamine derivative decreases the activity of the K + ATP channels in beta cells [19±21] .
Several other observations also favour verapamilinduced inhibition of K + ATP channels. Indeed, verapamil prevented the stimulatory effect of BPDZ 44 on 86 Rb outflow from prelabelled and perifused rat pancreatic islets. BPDZ 44 (Fig. 1) is a compound structurally related to both diazoxide and pinacidil and which has previously been shown to be a potent and specific activator of the beta-cell K + ATP channel [18] . Direct confirmation that verapamil modulates K might also interact with other K + channels equipping the beta-cell plasma membrane. Blockade by verapamil of ATP-and/or glibenclamide-sensitive K + currents has been previously described in heart cells [22, 23] and follicle-enclosed Xenopus oocytes [24] .
Because the primary effect of most insulin secretagogues is regarded as inhibition of the K + ATP channel, a phenomenon which in turn causes membrane depolarization with subsequent activation of voltage-sensitive Ca 2 + channels, it was essential to quantify the effects of verapamil on Ca 2 + fluxes and insulin release. Under experimental conditions in which verapamil clearly inhibited the K + ATP channels (i. e. in the absence of glucose or in the presence of a noninsulinotropic glucose concentration), the drug did not affect Ca 2 + movements, cytosolic free Ca 2 + concentration or insulin release.
There are two possible explanations of why verapamil inhibited K [8, 25] . In contrast, verapamil did not affect 45 Ca outflow and insulin release from islets exposed to a glucose-deprived medium or to a medium containing non-insulinotropic glucose concentrations. The same lack of verapamil effect on 45 Ca FOR was observed when experiments were conducted with Ca 2 + -depleted media. The ability of verapamil to inhibit Ca 2 + influx was further confirmed by its capacity to reduce the cytosolic Ca 2 + concentration in islet cells incubated in the presence of 11.1 mmol/l glucose. Finally, verapamil was also shown to inhibit the increase in 45 Ca outflow brought about by a sudden rise in the [8] . Collectively, these observations clearly indicate that, whenever a membrane depolarization promotes the activation of voltage-sensitive Ca 2 + channels, the major effect of verapamil is to block the influx of Ca 2 + ions. The precise mechanism(s) by which the phenylalkylamine reduces the K + ATP channel activity remain(s), however, unclear. The inhibitory effect of verapamil on K + ATP channels appears to be dependent on the phenylalkylamine structure and is not associated with the Ca 2 + channel blocking activity of the drug. Despite recent findings that verapamil increases the ATP/ADP 22 ratio in rat pancreatic islets [26] , it is unlikely that such an increase in the cellular energy state mediates the inhibition of K + ATP channels. Indeed, the verapamil-induced changes in nucleotide levels were ascribed to result from the reduction in Ca 2 + entry. Moreover, verapamil remained an effective K + ATP channel blocker in isolated inside-out patches where cell metabolism has been disrupted. The similarity between the effects of the Ca 2 + entry blocker verapamil and hypoglycaemic sulfonylureas [9, 21] on 86 Rb outflow and K + ATP currents might suggest the interaction with a target site exhibiting close and/or similar properties. In support of this idea, both verapamil and hypoglycaemic sulfonylureas have been shown to interact with membrane proteins belonging to the family of the ATP-binding cassette proteins [27] .
In conclusion, the present results clearly indicate that verapamil reduces the K + permeability of pancreatic beta cells. This effect is concentration-dependent, Ca 2 + -independent and appears to be inherent to the phenylalkylamine type Ca 2 + channel blockers. Our radioisotopic and electrophysiologic observations further reveal that the ªantagonisticº action of verapamil on K + permeability mainly results from the inhibition of ATP-sensitive K + channels. Such an inhibition was not associated with any increase in the secretory response.
